{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:12:13Z","timestamp":1778659933156,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"crossref","award":["2024AFB1046"],"award-info":[{"award-number":["2024AFB1046"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Peking University\u2013Merck Joint Laboratory of Infectious Disease Prevention and Control Technology Medical Innovation Fund","award":["10001202401"],"award-info":[{"award-number":["10001202401"]}]},{"name":"the National Health Public Talent Program of the National Disease Control and Prevention Administration","award":["S2025CF02"],"award-info":[{"award-number":["S2025CF02"]}]},{"name":"Key Research and Development Program of China","award":["2021YFC2301600"],"award-info":[{"award-number":["2021YFC2301600"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-42174-y","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T08:31:09Z","timestamp":1774513869000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["First serogroup Y meningitis outbreak in Hubei Province Central China linked to adolescent immunization gaps"],"prefix":"10.1038","volume":"16","author":[{"given":"Dan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingqing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongmei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"42174_CR1","unstructured":"1. World Health Organization (WHO). Meningococcal Meningitis Fact Sheet. WHO; Feb. 2018"},{"issue":"9580","key":"42174_CR2","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1016\/S0140-6736(07)61016-2","volume":"369","author":"D. S. Stephens","year":"2007","unstructured":"2.Stephens, D. S., Greenwood, B. & Brandtzaeg, P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 369 (9580), 2196\u20132210 (2007).","journal-title":"Lancet"},{"issue":"2","key":"42174_CR3","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1086\/649209","volume":"50","author":"A. C. Cohn","year":"2010","unstructured":"3.Cohn, A. C. et al. Changes in Neisseria meningitidis disease epidemiology in the United States, 1998\u20132007: implications for prevention of meningococcal disease. Clin. Infect. Dis. 50 (2), 184\u2013191 (2010).","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"42174_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1478-7954-11-17","volume":"11","author":"R. Z. Jafri","year":"2013","unstructured":"4.Jafri, R. Z. et al. Global epidemiology of invasive meningococcal disease. Popul. Health Metr. 11 (1), 17 (2013).","journal-title":"Popul. Health Metr."},{"issue":"9","key":"42174_CR5","first-page":"825","volume":"50","author":"L. C. Guo","year":"2016","unstructured":"5.Guo, L. C. et al. Epidemiological analysis on serogroup Y Neisseria meningitidis firstly isolated from patient in Tianjin. Chin. J. Prev. Med. 50 (9), 825\u2013827 (2016).","journal-title":"Chin. J. Prev. Med."},{"issue":"6","key":"42174_CR6","first-page":"612","volume":"79","author":"B. S. Li","year":"2019","unstructured":"6.Li, B. S. et al. The molecular characteristics of Neisseria meningitidis serogroup Y clonal complex 23 first emerge in China. J. Infect. 79 (6), 612\u2013625 (2019).","journal-title":"J. Infect."},{"issue":"11","key":"42174_CR7","first-page":"1295","volume":"28","author":"X. Xia","year":"2021","unstructured":"7.Xia, X. et al. Etiological characteristics of strains from cases of epidemic cerebrospinal meningitis due to newly isolated Neisseria meningitidis serogroups X and Y in Hunan Province. Pract. Prev. Med. 28 (11), 1295\u20131298 (2021).","journal-title":"Pract. Prev. Med."},{"issue":"11","key":"42174_CR8","first-page":"1222","volume":"36","author":"Q. He","year":"2021","unstructured":"8.He, Q., Zhang, X. Q., Lu, X. L., Jing, Q. L. & Shao, X. P. Liu MZ A pneumonia case caused by Neisseria meningitides serogroup Y ST-23 clonal complex. Dis. Surveill. 36 (11), 1222\u20131224 (2021).","journal-title":"Dis. Surveill"},{"issue":"5","key":"42174_CR9","first-page":"724","volume":"22","author":"G. S. Huang","year":"2022","unstructured":"9.Huang, G. S., Liu, M. Z., Ke, B. X. & Jiang, X. Etiology and epidemiological analysis on the first ST-1655 complex serogroup Y Neisseria meningitidis isolated from patient in Shantou. J. Trop. Med. 22 (5), 724\u20136731 (2022).","journal-title":"J. Trop. Med."},{"issue":"47","key":"42174_CR10","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.46234\/ccdcw2024.249","volume":"6","author":"Y. Guo","year":"2024","unstructured":"10.Guo, Y. et al. The First case of Serogroup Y Neisseria meningitidis and an expanded investigation of healthy carriers - Shijiazhuang City, Hebei Province, China, 2023. China CDC Wkly. 6 (47), 1242\u20131247 (2024).","journal-title":"China CDC Wkly."},{"key":"42174_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.12688\/wellcomeopenres.14826.1","volume":"3","author":"K. A. Jolley","year":"2018","unstructured":"11.Jolley, K. A., Bray, J. E. & Maiden, M. C. J. Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open. Res. 3, 124 (2018).","journal-title":"Wellcome Open. Res."},{"issue":"1","key":"42174_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1574-6976.2006.00053.x","volume":"31","author":"C. L. Trotter","year":"2007","unstructured":"12.Trotter, C. L. & Ramsay, M. E. Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines. FEMS Microbiol. Rev. 31 (1), 101\u2013107 (2007).","journal-title":"FEMS Microbiol. Rev."},{"issue":"12","key":"42174_CR13","doi-asserted-by":"publisher","first-page":"242","DOI":"10.46234\/ccdcw2024.048","volume":"6","author":"X. Zeng","year":"2024","unstructured":"13.Zeng, X. et al. An outbreak of serogroup Y meningococcal meningitis in a private secondary vocational school - Guangzhou City, Guangdong Province, China, 2023. China CDC Wkly. 6 (12), 242\u2013246 (2024).","journal-title":"China CDC Wkly."},{"issue":"6","key":"42174_CR14","first-page":"612","volume":"79","author":"B. Li","year":"2019","unstructured":"14.Li, B. et al. The molecular characteristics of Neisseria meningitidis serogroup Y clonal complex 23 first emerge in China. J. Infect. 79 (6), 612\u2013625 (2019).","journal-title":"J. Infect."},{"issue":"220 Suppl 4","key":"42174_CR15","doi-asserted-by":"publisher","first-page":"S266","DOI":"10.1093\/infdis\/jiz279","volume":"220","author":"A. C. Retchless","year":"2019","unstructured":"15.Retchless, A. C. et al. Toward a global genomic epidemiology of meningococcal disease. J. Infect. Dis. 220 (220 Suppl 4), S266\u2013S273 (2019).","journal-title":"J. Infect. Dis."},{"key":"42174_CR16","unstructured":"Meningococcal disease control in countries of the African meningitis belt. Wkly. Epidemiol. Rec. 90 (13), 123\u2013131 (2014)."},{"issue":"1","key":"42174_CR17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1574-6976.2006.00052.x","volume":"31","author":"D. A. Caugant","year":"2007","unstructured":"17.Caugant, D. A., Tzanakaki, G. & Kriz, P. Lessons from meningococcal carriage studies. FEMS Microbiol. Rev. 31 (1), 52\u201363 (2007).","journal-title":"FEMS Microbiol. Rev."},{"issue":"1","key":"42174_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/aje\/kwi160","volume":"162","author":"C. L. Trotter","year":"2005","unstructured":"18.Trotter, C. L., Gay, N. J. & Edmunds, W. J. Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination. Am. J. Epidemiol. 162 (1), 89\u2013100 (2005).","journal-title":"Am. J. Epidemiol."},{"issue":"4","key":"42174_CR19","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1007\/s40121-021-00499-3","volume":"10","author":"L. Soumahoro","year":"2021","unstructured":"19.Soumahoro, L., Abitbol, V., Vicic, N., Bekkat-Berkani, R. & Safadi, M. A. P. Meningococcal Disease Outbreaks: A moving target and a case for routine preventative vaccination. Infect. Dis. Ther. 10 (4), 1949\u20131988 (2021).","journal-title":"Infect. Dis. Ther."},{"issue":"7452","key":"42174_CR20","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1136\/bmj.328.7452.1339","volume":"328","author":"B. Purcell","year":"2004","unstructured":"20.Purcell, B. et al. Effectiveness of antibiotics in preventing meningococcal disease after a case: systematic review. BMJ 328 (7452), 1339 (2004).","journal-title":"BMJ"},{"key":"42174_CR21","first-page":"CD004785","volume":"4","author":"A. Fraser","year":"2006","unstructured":"21.Fraser, A., Gafter-Gvili, A., Paul, M. & Leibovici, L. Antibiotics for preventing meningococcal infections. Cochrane Database Syst. Rev. 4, CD004785 (2006).","journal-title":"Cochrane Database Syst. Rev."},{"key":"42174_CR22","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1017\/S0950268824001535","volume":"152","author":"M. Tin Tin Htar","year":"2024","unstructured":"22.Tin Tin Htar, M., Findlow, J., Balmer, P. & Swerdlow, D. Global epidemiology of serogroup Y invasive meningococcal disease: a literature review. Epidemiol. Infect. 152, e157. (2024).","journal-title":"Epidemiol. Infect."},{"issue":"6","key":"42174_CR23","first-page":"612","volume":"79","author":"B. S. Li","year":"2019","unstructured":"23.Li, B. S. et al. The molecular characteristics of Neisseria meningitidis serogroup Y clonal complex 23 first emerging in China. J. Infect. 79 (6), 612\u2013625 (2019).","journal-title":"J. Infect."},{"key":"42174_CR24","unstructured":"24. Taiwan Centers for Disease Control. National childhood immunization schedule (2015 revision)."},{"key":"42174_CR25","unstructured":"25. World Health Organization. Defeating meningitis by 2030: a global road map. WHO; 2021. https:\/\/www.who.int\/initiatives\/defeating-meningitis-by-2030. Accessed on July 10th, 2025."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42174-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42174-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42174-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:45:24Z","timestamp":1778658324000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42174-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["42174"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-42174-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"23 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The requirement of ethical approval was waived by Hubei Provincial Center for Disease Control and Prevention for the studies involving humans because meningococcal meningitis is a statutory infectious disease in China. The research involves meningococcal meningitis outbreak response and is exempt from ethical review according to the Law of the People\u2019s Republic of China on Prevention and Control of Infectious Diseases. This exemption is in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal participate"}},{"value":"This study involved public health outbreak response for a statutory infectious disease. All participants (or their guardians for minors) provided informed consent for epidemiological investigation, laboratory testing, and data collection. The study complied with the Declaration of Helsinki, and ethical approval was waived as per relevant regulations for infectious disease surveillance and response according to the Law of the People\u2019s Republic of China on Prevention and Control of Infectious Diseases.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"15021"}}